Elisabeth Formann

886 total citations
27 papers, 657 citations indexed

About

Elisabeth Formann is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Elisabeth Formann has authored 27 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 11 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in Elisabeth Formann's work include Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (6 papers). Elisabeth Formann is often cited by papers focused on Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (6 papers). Elisabeth Formann collaborates with scholars based in Austria, Australia and Germany. Elisabeth Formann's co-authors include Péter Ferenci, Petra Steindl‐Munda, Wolfgang Jessner, Hermann Laferl, Peter Ferenci, Rudolf Stauber, Michael Gschwantler, H. Brünner, Christian Datz and Lawrence Bennett and has published in prestigious journals such as The Lancet, Gastroenterology and Journal of Hepatology.

In The Last Decade

Elisabeth Formann

27 papers receiving 635 citations

Peers

Elisabeth Formann
Elisabeth Formann
Citations per year, relative to Elisabeth Formann Elisabeth Formann (= 1×) peers Laura Maiocchi

Countries citing papers authored by Elisabeth Formann

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Formann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Formann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Formann more than expected).

Fields of papers citing papers by Elisabeth Formann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Formann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Formann. The network helps show where Elisabeth Formann may publish in the future.

Co-authorship network of co-authors of Elisabeth Formann

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Formann. A scholar is included among the top collaborators of Elisabeth Formann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Formann. Elisabeth Formann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferenci, Péter, Hermann Laferl, Thomas–Matthias Scherzer, et al.. (2008). Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response. Gastroenterology. 135(2). 451–458. 201 indexed citations
2.
Jessner, Wolfgang, Michael Gschwantler, Elisabeth Formann, et al.. (2008). Very Early Viral Kinetics on Interferon Treatment in Chronic Hepatitis C virus Genotype 4 Infection. Antiviral Therapy. 13(4). 581–589. 5 indexed citations
3.
Jessner, Wolfgang, et al.. (2008). 798 VERY EARLY VIRAL KINETICS ON INTERFERON TREATMENT IN CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION. Journal of Hepatology. 48. S298–S298. 3 indexed citations
4.
Dzirlo, Larisa, Christian Müller, B Blaha, et al.. (2007). A mimic of sarcoidosis. The Lancet. 369(9575). 1832–1832. 11 indexed citations
5.
Jessner, Wolfgang, Thomas Watkins‐Riedel, Christian Müller, et al.. (2007). Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection. Journal of Viral Hepatitis. 14(11). 775–781. 1 indexed citations
6.
Sieghart, Wolfgang, Monika Homoncik, Bernd Jilma, et al.. (2006). Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C. Thrombosis and Haemostasis. 95(2). 260–266. 5 indexed citations
7.
Aberle, Judith H., Elisabeth Formann, Petra Steindl‐Munda, et al.. (2006). Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection. Journal of Clinical Virology. 36(1). 24–31. 56 indexed citations
8.
Formann, Elisabeth, et al.. (2006). Long‐term follow‐up of chronic hepatitis C patients with sustained virological response to various forms of interferon‐based anti‐viral therapy. Alimentary Pharmacology & Therapeutics. 23(4). 507–511. 61 indexed citations
9.
Formann, Elisabeth, et al.. (2005). Tongue and Skin Hyperpigmentation During PEG-Interferon-alpha/Ribavirin Therapy in Dark-Skinned Non-Caucasian Patients with Chronic Hepatitis C. The American Journal of Gastroenterology. 101(1). 197–198. 22 indexed citations
10.
Kramer, Ludwig, Harald Hofer, Edith Bauer, et al.. (2005). Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. AIDS. 19(Suppl 3). S85–S92. 51 indexed citations
11.
12.
Formann, Elisabeth, Rudolf Stauber, Doris‐Maria Denk, et al.. (2004). Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon/Ribavirin. The American Journal of Gastroenterology. 99(5). 873–877. 32 indexed citations
13.
Homoncik, Monika, Arnulf Ferlitsch, Péter Ferenci, et al.. (2004). Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 21(1). 49–55. 15 indexed citations
14.
Formann, Elisabeth, Wolfgang Jessner, Lawrence Bennett, & Peter Ferenci. (2003). Twice‐weekly administration of peginterferon‐α‐2b improves viral kinetics in patients with chronic hepatitis C genotype 1. Journal of Viral Hepatitis. 10(4). 271–276. 66 indexed citations
15.
Ferenci, Peter, Hermann Laferl, H. Brünner, et al.. (2003). Prospective evaluation of the 24 hour interferon-induced decline in hepatitis C virus genotype 1 load to predict response to peginterferon-alfa2a/ribavirin combination therapy. Gastroenterology. 124(4). A767–A767. 6 indexed citations
16.
Preyer, Oliver, Andreas Obermair, Elisabeth Formann, et al.. (2002). The Impact of Positive Peritoneal Washings and Serosal and Adnexal Involvement on Survival in Patients with Stage IIIA Uterine Cancer. Gynecologic Oncology. 86(3). 269–273. 23 indexed citations
17.
Jessner, Wolfgang, Thomas Watkins‐Riedel, Elisabeth Formann, Petra Steindl‐Munda, & Peter Ferenci. (2002). Hepatitis C viral dynamics: basic concept and clinical significance. Journal of Clinical Virology. 25. 31–39. 10 indexed citations
18.
Formann, Elisabeth, et al.. (1968). The angular distribution of scattered and sputtered 40-keV particles on polycrystalline targets. Canadian Journal of Physics. 46(6). 753–758. 11 indexed citations
19.
Formann, Elisabeth, et al.. (1966). Anomalous angular distribution of scattered heavy ions. Physics Letters. 23(9). 558–559. 4 indexed citations
20.
Formann, Elisabeth & F.P. Viehböck. (1966). Preparation of thick isotopic targets inside an electromagnetic isotope separator. Nuclear Instruments and Methods. 42(2). 331–332. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026